NF-κB mediates the induction of Fas receptor and Fas ligand by microcystin-LR in HepG2 cells

Molecular and Cellular Biochemistry

Volumn 352, Issue 1-2, 2011, Pages 209-219

  Feng, Gong ^a,b   Abdalla, Musa ^c   Li, Ying ^b   Bai, Yansheng ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Anong Biotech Institute   (China)

^c ROSS UNIVERSITY SCHOOL OF MEDICINE   (Dominica)

Author keywords

Apoptosis; Fas ligand; Fas receptor; Microcystin LR; NF B

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICROCYSTIN LR; SYNAPTOTAGMIN I;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEPG2; DNA FRAGMENTATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE SILENCING; GENE TRANSLOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CELL; NICK END LABELING; PROTEIN EXPRESSION; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANTIGENS, CD95; BASE SEQUENCE; CELL LINE; DNA PRIMERS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HUMANS; IN SITU NICK-END LABELING; MICROCYSTINS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79959256145     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0756-y     Document Type: Article

References (43)

1. Dittmann E, Wiegand C (2006) Cyanobacterial toxins - occurrence, biosynthesis and impact on human affairs. Mol Nutr Food Res 50(1):7-17 (Pubitemid 43155092)
2. van Apeldoorn ME, van Egmond HP, Speijers GJ, Bakker GJ (2007) Toxins of cyanobacteria. Mol Nutr Food Res 51(1):7-60 (Pubitemid 46144763)
3. Honkanen RE, Zwiller J, Moore RE, Daily SL, Khatra BS, Dukelow M, Boynton AL (1990) Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases. J Biol Chem 265(32):19401-19404 (Pubitemid 120013875)
4. Goldberg J,HuangHB,KwonYG,Greengard P, NairnAC, Kuriyan J (1995) Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1. Nature 376(6543):745-753
5. Craig M, Luu HA, McCready TL, Williams D, Andersen RJ, Holmes CF (1996) Molecular mechanisms underlying he interaction of motuporin and microcystins with type-1 and type-2A protein phosphatases. Biochem Cell Biol 74(4):569-578 (Pubitemid 126734119)
6. Fischer WJ, Hitzfeld BC, Tencalla F, Eriksson JE, Mikhailov A, Dietrich DR (2000) Microcystin-LR toxicodynamics, induced pathology, and immunohistochemical localization in livers of blue-green algae exposed rainbow trout (Oncorhynchus mykiss). Toxicol Sci 54(2):365-373
7. Ding WX, Shen HM, Ong CN (2000) Critical role of reactive oxygen species and mitochondrial permeability transition in microcystin-induced rapid apoptosis in rat hepatocytes. Hepatology 32(3):547-555
8. Bouaicha N, Maatouk I (2004) Microcystin-LR and nodularin induce intracellular glutathione alteration, reactive oxygen species production and lipid peroxidation in primary cultured rat hepatocytes. Toxicol Lett 148(1-2):53-63 (Pubitemid 38264522)
9. Gupta N, Pant SC, Vijayaraghavan R, Rao PV (2003) Comparative toxicity evaluation of cyanobacterial cyclic peptide toxin microcystin variants (LR, RR, YR) in mice. Toxicology 188(2-3):285-296 (Pubitemid 36588906)
10. Eriksson JE, Gronberg L, Nygard S, Slotte JP, Meriluoto JA (1990) Hepatocellular uptake of 3H-dihydromicrocystin-LR, a cyclic peptide toxin. Biochim Biophys Acta 1025(1):60-66 (Pubitemid 20183620)
11. Fischer WJ, Altheimer S, Cattori V, Meier PJ, Dietrich DR, Hagenbuch B (2005) Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. Toxicol Appl Pharmacol 203(3):257-263 (Pubitemid 40311872)
12. Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424 (Pubitemid 29449198)
13. Maher S, Toomey D, Condron C, Bouchier-Hayes D (2002) Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol Cell Biol 80(2):131-137 (Pubitemid 34298085)
14. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81(4):505-512
15. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14(22):5579-5588
16. Guicciardi ME, Gores GJ (2009) Life and death by death receptors. FASEB J 23(6):1625-1637
17. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364(6440):806-809 (Pubitemid 23261761)
18. Rouquet N, Carlier K, Briand P, Wiels J, Joulin V (1996) Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes. Biochem Biophys Res Commun 229(1):27-35 (Pubitemid 27013705)
19. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99(3):403-413 (Pubitemid 27414797)
20. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C, Tschopp J (1996) Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 133(2):335-343 (Pubitemid 26132532)
21. Aoudjehane L, Podevin P, Scatton O, Jaffray P, Dusanter-Fourt I, Feldmann G, Massault PP, Grira L, Bringuier A, Dousset B, Chouzenoux S, Soubrane O, Calmus Y, Conti F (2007) Interleukin-4 induces human hepatocyte apoptosis through a Fasindependent pathway. FASEB J 21(7):1433-1444 (Pubitemid 46684846)
22. Javitt NB (1990) Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J 4(2):161-168
23. van ISC, Zegers MM, Kok JW, Hoekstra D (1997) Segregation of glucosylceramide and sphingomyelin occurs in the apical to basolateral transcytotic route in HepG2 cells. J Cell Biol 137(2):347-357 (Pubitemid 27181289)
24. van der Wouden JM, van ISC, Hoekstra D (2002) Oncostatin M regulates membrane traffic and stimulates bile canalicular membrane biogenesis in HepG2 cells. EMBO J 21(23):6409-6418
25. Mersch-Sundermann V, Knasmuller S, Wu XJ, Darroudi F, Kassie F (2004) Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents. Toxicology 198(1-3):329-340 (Pubitemid 38609044)
26. Ohgaki R, Matsushita M, Kanazawa H, Ogihara S, Hoekstra D, van Ijzendoorn SC (2010) The Na+/H+ exchanger NHE6 in the endosomal recycling system is involved in the development of apical bile canalicular surface domains in HepG2 cells. Mol Biol Cell 21(7):1293-1304
27. Baichwal VR, Baeuerle PA (1997) Activate NF-κB or die? Curr Biol 7(2):R94-R96
28. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr (1999) NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19(8):5785-5799 (Pubitemid 29339933)
29. Barkett M, Gilmore TD (1999) Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18(49):6910-6924
30. Dutta J, Fan Y, Gupta N, Fan G, Gelinas C (2006) Current insights into the regulation of programmed cell death by NF-κB. Oncogene 25(51):6800-6816 (Pubitemid 44657853)
31. Chan H, Bartos DP, Owen-Schaub LB (1999) Activation-dependent transcriptional regulation of the human Fas promoter requires NF-κB p50-p65 recruitment. Mol Cell Biol 19(3): 2098-2108 (Pubitemid 29098268)
32. Fu WY, Chen JP, Wang XM, Xu LH (2005) Altered expression of p53, Bcl-2 and Bax induced by microcystin-LR in vivo and in vitro. Toxicon 46(2):171-177
33. Fladmark KE, Brustugun OT, Hovland R, Boe R, Gjertsen BT, Zhivotovsky B, Doskeland SO (1999) Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors. Cell Death Differ 6(11):1099-1108
34. Holtz-Heppelmann CJ, Algeciras A, Badley AD, Paya CV (1998) Transcriptional regulation of the human FasL promoter-enhancer region. J Biol Chem 273(8):4416-4423 (Pubitemid 28103179)
35. Mondor I, Schmitt-Verhulst AM, Guerder S (2005) RelA regulates the survival of activated effector CD8 T cells. Cell Death Differ 12(11):1398-1406 (Pubitemid 41521930)
36. Novac N, Baus D, Dostert A, Heinzel T (2006) Competition between glucocorticoid receptor and NFκB for control of the human FasL promoter. FASEB J 20(8):1074-1081 (Pubitemid 44943903)
37. Campbell KJ, Rocha S, Perkins ND (2004) Active repression of antiapoptotic gene expression by RelA(p65) NF-κB. Mol Cell 13(6):853-865 (Pubitemid 38438480)
38. Ashikawa K, Shishodia S, Fokt I, Priebe W, Aggarwal BB (2004) Evidence that activation of nuclear factor-κB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem Pharmacol 67(2):353-364 (Pubitemid 38112765)
39. Campbell KJ, Witty JM, Rocha S, Perkins ND (2006) Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-κB transactivation. Cancer Res 66(2):929-935 (Pubitemid 43165960)
40. Jones BE, Lo CR, Liu H, Pradhan Z, Garcia L, Srinivasan A, Valentino KL, Czaja MJ (2000) Role of caspases and NF-κB signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol 278(5):G693-G699 (Pubitemid 30366421)
41. Roman J, Colell A, Blasco C, Caballeria J, Pares A, Rodes J, Fernandez-Checa JC (1999) Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: effect on transcription factors AP-1 and NF-κB. Hepatology 30(6):1473-1480
42. Ghosh S, May MJ, Kopp EB (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260 (Pubitemid 28183365)
43. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M (1997) A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388(6642):548-554 (Pubitemid 27339997)